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ABSTRACT
Autophagy and the ubiquitin-proteasome system (UPS) control thymus cell 
homeostasis under resting and endoplasmic reticulum (ER) stress conditions. 
Several evidence support a cross-talk between UPS and autophagy; abrogation of 
UPS responses stimulates autophagy, and vice versa the inhibition of autophagy 
alters the UPS functions. 
Herein, we found that TRPV1 activation induces ER stress, proteasome dysfunction 
and autophagy in thymocytes by modulating the expression of UPR-related genes. 
The TRPV1-mediated autophagy prevents the UPR activation by inhibiting BiP, Grp94 
and ERp57 chaperone protein expression. 
Thymocytes from TRPV1 KO mice display both autophagy and proteasome 
dysfunctions, resulting in increased apoptotic cells and reduced total DP thymocyte 
number. 
In addition, positive selection of thymocytes triggered by anti-TCRβ/CD2 Ab-
mediated costimulation induces apoptosis in thymocytes from TRPV1 KO as compared 
with WT mice. Stimulation of TRPV1 KO thymocytes with anti-TCRβ/CD2 mAbs 
modulates the expression of CD4 antigen on purified DP thymocytes, with reduced 
number of mature, single positive (SP) CD4 and increased number of immature SP 
CD4low and DP CD4lowCD8+ thymocytes, further supporting the intrinsic role of TRPV1 
in T cell maturation. Finally, a reduction in CD8+ and CD4+ T cells is evidenced in the 
peripheral blood and spleen of TRPV1 KO, as compared with WT mice. Therapeutic 
strategy by restraining or stimulating the TRPV1 expression and functions in 
thymocytes might represent a new pharmacological tool in the regulation of different 
inflammatory T cell responses.
INTRODUCTION
Autophagy and the ubiquitin-proteasome system 
(UPS) constitute the major intracellular degradation 
pathways controlling cellular homeostasis under normal 
conditions and cellular stress [1]. Autophagy is a cellular 
adaptive response to stress conditions, such as nutrient, 
growth factor deprivation or oxidative stress. This 
process is mainly involved in the degradation of long-
lived proteins and excess/damaged organelles [2]. The 
UPS represents the principal degradation mechanism for 
short-lived proteins labeled with ubiquitin [3]. Unfolded 
or misfolded proteins are tagged for degradation via 
endoplasmic reticulum-associated degradation (ERAD). 
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Continued accumulation of incorrectly folded proteins 
triggers the unfolded protein response (UPR) in the 
attempt to resolve ER stress and reestablish the folding 
homeostasis [4-6]. Mild to moderate ER stress induces 
autophagy as a compensatory cell survival mechanism by 
relieving proteasome inhibitor-induced ER stress, whereas 
severe or chronically prolonged ER stress deteriorates 
cellular functions with a switch from an adaption program 
to apoptotic cell death [7, 8]. In cases in which mild ER 
stress activates all UPR sensors, survival is favored as a 
consequence of increased instability of the mRNAs and 
proteins that promote apoptosis compared to those that 
facilitate adaptation and autophagic survival [8]. Several 
evidence support the existence of an interplay between the 
UPS and autophagy [9]: inhibition of UPS often induces 
autophagy whilst inhibition of autophagy alters the UPS 
function [1]. 
Autophagy is vital for thymocytes during stress 
conditions such as starvation, activation, growth and 
proliferation to provide cells with essential metabolic 
intermediates. This process is involved in T cell thymic 
development and the thymus exhibits a considerable high 
amount of constitutive basal autophagy compared to 
other tissues. In thymic antigen presenting cells (APCs), 
intracellular peptides can be presented on MHC class II 
through autophagy [10]. 
Members of the transient receptor potential (TRP) 
ion channel family have been shown to mediate cellular 
Ca2+ homeostasis, initiate ER stress and stimulate UPR 
and apoptosis, or autophagic survival in normal and 
neoplastic cells [11]. In this regard, TRPV1 is a cation 
channels expressed on thymocytes as well as on naïve and 
effector CD4+ T lymphocytes and Jurkat T cell leukemia 
[12, 13], and a contribute of TRPV1 in TCR-induced Ca2+ 
influx and proper downstream TCR signaling leading 
to T cell activation has been recently reported [14]. 
Previously, we have reported that the TRPV1 agonist, 
capsaicin (CPS) modulates T cell differentiation and 
functions by regulating the apoptosis of distinct thymocyte 
subpopulations in rats [12]. Moreover, the presence of an 
interplay between autophagic survival and apoptotic cell 
death in response to stress signals has been demonstrated 
in the mouse thymus [15, 16]. Triggering of TRPV1 by 
the specific agonist CPS, induces autophagic survival in 
mouse DPdull thymocytes. TRPV1-induced autophagy is 
Atg4C- and Atg6-dependent and, requires [Ca2+]i increase 
and reactive oxygen species (ROS) generation that induces 
Atg4C protein oxidation resulting in AMPK activation. In 
addition, the inhibition of TRPV1-mediated autophagy by 
the 3-MA autophagic inhibitor decreases Atg4C, Bcl-XL, 
Irgm1 and Beclin-1 expression and induces caspase-3-
dependent apoptosis of DPdull thymocytes [15]. 
At present, the molecular mechanism involved in 
thymus maturation by regulating thymocyte fate has been 
only partially investigated. Thus, the aim of the present 
work was to evaluate the role of TRPV1 in the cross-talk 
between ER stress, proteasome and autophagy responses, 
resulting in thymocyte survival or death in steady state and 
during thymic maturation.
RESULTS
CPS inhibits cellular proteasome function in a 
TRPV1-dependent manner
Lysates from CPS-treated thymocytes were analyzed 
for proteasome activity. As shown in Figure 1A, exposure 
of thymocytes to the TRPV1 agonist, CPS resulted in 
a time-dependent decrease of ChT-L, T-L, PGPH and 
26S proteasome ChT-L activities. To further confirm the 
effect of CPS on cellular proteasome, the expression 
level of the proteasome target protein p27 was measured 
by immunoblot analysis. Figure 1B demonstrates that 
TRPV1-mediated proteasome inhibition correlates 
with increased levels of p27 in thymocytes. Then, the 
involvement of ROS generation and the increase of [Ca2+]
i in TRPV1-mediated inhibition of the proteasome activity 
was evaluated by using the ROS scavenger NAC, the 
Ca2+ blocker EDTA and the specific TRPV1 antagonist, 
capsazepine (CPZ). NAC, EDTA and CPZ completely 
reverted the inhibition of proteasome functionality (Figure 
2A) and the p27 accumulation (Figure 2B) induced 
by CPS in a TRPV1-mediated manner after 2 hours of 
treatment.
The ER stress inhibitor 4-PBA abrogates the 
CPS-induced autophagy promoting thymocyte 
apoptosis
Previously, it has been demonstrated that proteasome 
inhibition activates autophagy to purge polyubiquitinated 
protein aggregates with the aim to alleviate ER stress 
and the UPR [17]. Starting from these results and taking 
into account our recent data demonstrating that TRPV1 
activation by CPS triggers autophagy counteracting 
apoptotic cell death of DPdull thymocytes [15], we 
decided to evaluate whether autophagy could occur as a 
consequence of CPS-induced proteasome inhibition and 
ER stress. To this aim, thymocytes were treated with CPS 
in combination with 4-PBA, a small chemical chaperone 
that interacts with the hydrophobic domains of misfolded 
proteins, preventing their aggregation and supporting the 
correct protein folding [18]. The autophagy pathway was 
evaluated by immunoblotting using specific anti-LC3 and 
-p62 antibodies. In fact, during autophagy, the cytosolic 
form of LC3 (LC3I) binds phosphatidylethanolamine to 
form LC3-phosphatidylethanolamine conjugate (LC3II), 
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Figure 1: CPS inhibits cellular proteasome activity. A. WT thymocytes were subjected to enzymatic proteasome activity assay 
after 30, 60 and 120 minutes of CPS treatment. Data, shown as percentage of proteasome activity, are from one representative experiment 
out of three separate experiments. Error bars are relative to three replicates. *p < 0.01 vs untreated cells. B. Western blot analysis and 
densitometric quantification of p27 protein levels in thymocytes treated for up to 120 minutes with CPS. p27 densitometry values were 
normalized to GAPDH used as loading control. Blots are representative of one of three separate experiments. *p < 0.01 treated vs untreated 
cells.
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Figure 2: CPS-mediated inhibition of enzymatic proteasome activity is ROS-, Ca2+- and TRPV1- dependent. A. 
Enzymatic proteasome activities were assessed in WT thymocytes pre-treated with NAC, EDTA and CPZ for 60 minutes and then treated 
with CPS for 120 minutes. Data, shown as percentage of proteasome activity, are from one representative experiment out of three separate 
experiments. Error bars are relative to three replicates. *p < 0.01 vs untreated cells; **p < 0.01 vs CPS-treated cells. B. Western blot analysis 
and densitometric quantification of p27 protein levels in thymocytes treated as above described. p27 densitometric values were normalized 
to GAPDH used as loading control. Blots are representative of one of three separate experiments. #p < 0.01 vs untreated; **p < 0.01 vs 
CPS-treated cells. 
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which is recruited to autophagosomal membranes [19], 
whereas the receptor for cargo p62 is degraded [20]. Our 
results demonstrated that TRPV1-induced autophagy 
depends on ER stress, as 4-PBA completely inhibited 
LC3II formation and p62 degradation (Figure 3A). 
In addition, Annexin V/PI or CD4/CD8α staining 
followed by FACS analysis revealed that 4-PBA in 
combination with CPS increases the percentage of 
Annexin V+PI- early (21.33%) and Annexin V+PI+ late 
(3.93%) thymocytes (Figure 3B), and reduces the TRPV1-
dependent increase of DPdull thymocytes (Figure 3C). 
Similar results were obtained in CPS-treated thymocytes 
pretreated with the autophagic inhibitor CQ or with the 
ROS scavenger NAC (Figure 3C). In addition, no major 
Figure 3: The 4-PBA abrogates the CPS-induced autophagy and reduces the DPdull thymocyte subpopulation. A. 
Western blot analysis of LC3 and p62 protein in WT thymocytes pre-treated with 4-PBA for 60 minutes and then treated for 120 minutes 
with CPS. The ratio of LC3 II/I was calculated from densitometric data. p62 densitometric values were normalized to GAPDH used as 
loading control. Blots are representative of one of three separate experiments. *p < 0.01 vs untreated cells, **p < 0.01 vs CPS-treated 
cells. B. Flow cytometric analysis was performed by Annexin V-FITC and PI double-staining of WT thymocytes, pre-treated with 4-PBA 
for 60 minutes and then treated for 120 minutes with CPS. Data represent the percentage of PI and/or Annexin V positive cells. One 
representative out of three independent experiments is shown. C. Thymocytes, pre-treated with 4-PBA, CQ or NAC for 60 minutes and 
then treated for 120 minutes with CPS, were stained with anti-CD4-PE and anti-CD8-Cy5 mAbs and analyzed by FACS. The black gate 
indicates the DPdull subpopulation. One representative out of three independent experiments is shown.
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changes in the expression levels of the activation markers 
CD25 and CD69 were found on CPS-treated as compared 
with untreated thymocytes (Supplementary Figure 1).
TRPV1 activation modulates the expression of 
UPR-related genes
UPR activation, upon proteasome dysfunction and 
ER stress, is a well-documented process [21-23]. Based 
on these observations, we investigated the effect of the 
TRPV1 agonist CPS on the expression of UPR components 
in thymocytes at 1 hour after treatment by RT-PCR array. 
In particular, the comparison of gene expression levels 
of CPS-treated with untreated thymocytes (Table 1), 
demonstrates that Hspa5 (Bip) and Hspa1 (heat shock 
proteins involved in protein folding), Dnajb9 (regulator 
of the ATPase activity of 70 kDa heat shock proteins), 
Bax (pro-apoptotic protein), Xbp1 (transcription factor 
promoting the expression of genes involved in protein 
degradation), Insig1 (involved in cell growth) Mbtps2 
(regulators of oxidative stress susceptibility) and the Rpn1 
(part of the subunit of the 26S proteasome) are down-
regulated, whereas Derlin-1 (functional component of 
ERAD and autophagy), Derlin-2 (functional component 
of ERAD) and Ero1lb (oxidoreductase involved in 
protein folding) are up-regulated. Overall, these findings 
demonstrate that CPS inhibits the expression of UPR and 
apoptosis genes and enhances that involved in modulation 
of ERAD and autophagy processes. 
The autophagy and ER stress inhibitors revert the 
TRPV1-mediated UPR down-regulation in CPS-
treated thymocytes
The TRPV1-induced changes in the UPR gene 
expression (Table 1) prompted us to investigate by western 
blot analysis, the expression of UPR proteins such as BiP, 
Grp94 and ERp57 chaperones, in thymocytes treated 
for different times (1, 2 and 4h) with CPS. We found 
that CPS decreases in a time-dependent manner, BiP, 
Grp94 and ERp57 protein expression (Figure 4A, 4B). 
Pretreatment of thymocytes with CQ or 4-PBA, before 
CPS exposure, completely reverted the CPS-induced UPR 
protein reduction, in a time-dependent manner, allowing 
their accumulation (Figure 4A, 4C), suggesting that CPS-
stimulated autophagy prevents the ER stress-induced 
UPR.
Figure 4: CPS reduces UPR protein levels, and autophagy reverts CPS-induced inhibitory effects. A. Western blot analysis 
and densitometric quantification of Grp94, BiP and ERp57 protein levels in WT thymocytes pre-treated with CQ and 4PBA for 1h and 
then treated for up to 4h with CPS. Blots are representative of one of three separate experiments. B. Densitometric quantification of Grp94, 
BiP and ERp57 protein levels in WT thymocytes treated with CPS for different times. Densitometric values were normalized to GAPDH 
used as loading control and represent the mean ± SEM of three separate experiments. *p < 0.01 vs untreated cells. C. Densitometric 
quantification of Grp94, BiP and ERp57 protein levels in thymocytes pre-treated with CQ and 4PBA and then treated with CPS. *p < 0.01 
vs CPS-treated cells. Densitometric values were normalized to GAPDH used as loading control and represent the mean ± SEM of three 
separate experiments. 
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Thymocytes from TRPV1 KO mice display both 
autophagy and proteasome dysfunctions
Since a role for TRPV1 in CPS-induced autophagy in 
thymocytes was found [15], we evaluated the consequence 
of TRPV1 genetic deletion on thymic autophagy. Our 
results showed that TRPV1 KO thymocytes express 
higher basal levels of p62 protein compared with WT cells 
(Figure 5A). Moreover, differently from WT thymocytes 
[15], TRPV1 KO thymocytes failed to activate the 
autophagy when stimulated with the autophagy inducer 
rapamycin (Figure 5B). Since the increase of p62 protein 
levels and the autophagic dysfunction result in the 
inhibition of proteasome [24, 25], the proteasome function 
was evaluated in TRPV1 KO and WT thymocytes. A 
decrease in the ChT-L, T-L, PGPH and 26S proteasome 
ChT-L activities (Figure 5C), a reduction of p27 protein 
and AMPK phosphorylation levels (Figure 5D and 5E) 
were found in TRPV1 KO thymocytes compared with WT 
cells. In addition, the apoptotic regulator Atf4 transcription 
factor (Figure 5F) and ERp57 (Figure 5G) protein levels 
were up regulated whereas BiP (Figure 5H) and Grp94 
(Figure 5I) UPR proteins were reduced in TRPV1 KO 
compared with WT thymocytes. Overall, these findings 
demonstrate that the expression of TRPV1 in thymocytes 
Figure 5: Knock-out of TRPV1 gene affects autophagy, proteasome and UPR protein expression in thymocytes. A. 
Western blot analysis and densitometric quantification of basal p62 protein levels in WT and TRPV1 KO thymocytes. Densitometric 
values were normalized to GAPDH used as loading control. Blots are representative of one of three separate experiments, *p < 0.01 vs WT 
thymocytes. B. Western blot analysis and densitometric quantification of LC3 and p62 protein levels in TRPV1 KO thymocytes treated 
for up to 4 h with rapamycin. Densitometric values were normalized to GAPDH used as loading control. Blots are representative of one 
of three separate experiments, *p < 0.01 vs CPS-treated cells for 0.5h or untreated cells. C. Thymocytes from WT and TRPV1 KO mice 
were subjected to enzymatic proteasome activity assay. Data shown as percentage of inhibition are representative of one of three separate 
experiments, *p < 0.01 TRPV1 KO vs WT thymocytes. D-I. Western blot analysis and densitometric quantification of p27 D., pAMPK/
AMPK E., ATF-4 F., ERp57 G., Bip H. and Grp94 I. protein levels in WT and TRPV1 KO thymocytes. Densitometric values were 
normalized to GAPDH used as loading control. Blots are representative of one of three separate experiments, *p < 0.01 vs WT thymocytes.
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is crucial in regulating autophagy, apoptosis and UPR 
activity. 
Loss of TRPV1 increases the apoptosis, reduces 
the total thymocyte number and affectes 
thymocyte distribution
Then we evaluated whether knockout of TRPV1 
gene could affect thymocyte number and distribution. To 
this purpose, freshly isolated thymocytes from TRPV1 KO 
and WT mice were counted and then labeled with Annexin 
V. Our findings show a reduction in total thymocyte count 
(Figure 6A), that is associated with a parallel increase in 
the percentage of Annexin V+ thymocytes (Figure 6B). 
In addition, knockout of TRPV1 affected thymocyte 
cell distribution. Thus, a marked reduction of total DP 
thymocyte number (Figure 6C) was observed in the 
thymus from TRPV1 KO respect to WT mice. 
Positive selection is impaired in TRPV1 KO 
thymocytes
We have previously reported the role of TRPV1 
in thymocyte differentiation by regulating the crosstalk 
between autophagic survival and apoptotic cell death [15]. 
To understand the contribution of TRPV1 in thymocyte 
maturation, we mimicked positive selection by stimulating 
TRPV1 KO and WT thymocytes for 18h with anti-TCRβ 
plus anti-CD2 mAbs and allowing recovery for 12h [26]. 
Since positive selection is an essential step for thymocyte 
survival and TCRβ/CD2 coengagment promotes anti-
apoptotic signals [27], we evaluated the extent of 
apoptotic cell death in un-stimulated and stimulated 
TRPV1 KO and WT thymocytes by cytofluorimetric 
analysis. As expected, positive selection promotes cell 
survival in WT thymocytes, as indicated by the reduced 
percentage of Annexin V+ cells. On the contrary, an 
impairment of positive selection was observed in TRPV1 
KO thymocytes as shown by the increased frequency of 
apoptotic cells (Figure 7A). These results prompted us 
to evaluate the outcome of positive selection, in highly 
purified ( > 97%) TRPV1 KO and WT CD4+CD8+ DP 
thymocytes, in response to TCRβ plus CD2 stimulation. 
Since previous results showed that the positive selection 
of DP cells promotes the maturation of CD4+ thymocytes 
[26], we performed cytofluorimetric analysis to assess the 
expression of CD4 and CD8 co-receptors. We found that 
the maturation process is promoted in both TRPV1 KO 
and WT thymocytes, as revealed by the modulation of 
CD4 expression; however, in stimulated TRPV1 KO DP 
thymocytes, a reduced number of total SP CD4 thymocytes 
(44.8%) was observed with respect to WT thymocytes 
(53.6%) (Figure 7B). In addition, CD4 expression levels 
on mature SP cells was lower in TRPV1 KO (CD4high 
13.2% and CD4low 31.6%) with respect to WT thymocytes 
(CD4high 28.7% and CD4low 24.9%) (Figure 7B). Finally, 
stimulation of positive selection also induced a marked 
increase in the percentage of immature CD4lowCD8+ DP 
subpopulation in TRPV1 KO (32.7%) as compared with 
WT thymocytes (13.3%) (Figure 7B). 
Based on these findings, demonstrating that the 
absence of TRPV1 increases the basal level of apoptotic 
thymocytes and impairs thymic positive selection, we 
finally evaluated the distribution of T lymphocytes in 
the peripheral blood and spleen. PBMC and splenic 
lymphocytes from TRPV1 KO and WT control mice 
were purified by Lympholyte density gradient, stained 
with anti-mouse CD4 and CD8 mAbs and evaluated by 
cytofluorimetric and FACS analysis. We observed that 
the percentage of mature CD8+ and CD4+ T cells in the 
peripheral blood and spleen was significantly lower in 
TRPV1 KO vs WT mice (Figure 7C) suggesting that 
the defect in T cell numbers in the periphery of TRPV1 
deficient mice may be the result of the impairment of their 
maturation in the thymus. 
Figure 6: Increased basal levels of apoptotic thymocytes and reduced total thymocyte number in TRPV1 KO mice. 
Freshly purified thymocytes from WT and KO mice were counted using trypan blue solution A., or stained with Annexin-V FITC and 
analyzed by FACS analysis B. Data are the mean ± SEM of three separate experiments, *p < 0.01 vs WT thymocytes. C. From the total 
number of cells per thymus, the relative number of cells in each CD4/CD8 subset was determined staining TRPV1 KO and WT thymocytes 
with anti-CD4-PE and anti-CD8-Cy5 mAbs and using FACS analysis. Data are the mean ± SEM of three separate experiments *p < 0.01 
TRPV1 KO vs WT thymocytes.
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Figure 7: Knock-out of TRPV1 gene impairs positive thymic selection and affects peripheral blood and spleen CD4+ 
and CD8+ T cell numbers. A. Thymocytes from WT and KO mice, stimulated with anti-TCRβ plus anti-CD2 mAbs after 18h of culture 
and 12h of recovery, were analyzed by FACS analysis. One representative out of three independent experiments is shown. B. Purified DP 
thymocytes from TRPV1 KO and WT mice stimulated with TCRβ plus CD2 mAbs for 18h, followed by 12h recovery, were stained with 
anti-CD4-PE and anti-CD8-Cy5 mAbs and analyzed by FACS. One representative out of three independent experiments is shown. C. Blood 
and spleen PBMC from WT and KO thymocytes were stained with anti-CD4-PE and anti-CD8-Cy5 mAbs and analyzed by FACS. One 
representative out of three independent experiments is shown in each panel.
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DISCUSSION
Several evidence support the existence of a cross-
talk between UPS and autophagy [9, 28]. Proteasome 
inhibitors induce autophagy by triggering ER stress [17]; 
conversely, suppression of both proteasome and autophagy 
has been shown to enhance apoptotic cell death [29]. 
The specific TRPV1 agonist CPS has been found 
to inhibit the proteasome [30, 31] and trigger autophagy 
[15, 32, 33], however, the relationship between these 
degradation systems in thymocytes and the role of TRPV1 
have not been addressed so far.
Herein, we found that TRPV1-dependent autophagy 
occurs as a consequence of proteasome inhibition and 
ER stress triggered by TRPV1. Reduced 20 and 26S 
proteasome activities and increased p27 expression were 
found in CPS-treated thymocytes, and this effect was 
TRPV1-, ROS- and [Ca2+]i rise-dependent.
In fact, pretreatment of thymocytes with the 4-PBA 
that reduces ER stress [18, 34, 35] before the addition of 
CPS, inhibited LC3II generation and p62 degradation, 
increased the percentage of AnnexinV+ apoptotic cells and 
completely reverted the CPS-induced increase of DPdull 
thymocytes, similarly to the autophagic inhibitor CQ. 
TRPV1 triggering by CPS resulted in inhibition of UPR 
and apoptosis as well as increase of ERAD and autophagic 
gene expression. Since a role of Ero1lb in setting ER redox 
potential and proper ER folding activity [36] and CPS 
in disrupting redox state by promoting ROS generation 
[37], the increased Ero1lb mRNA levels we found in CPS 
treated thymocytes could be the result of CPS-induced 
TRPV1-mediated ROS generation [15] altering ER redox 
homeostasis. In addition, CPS exposure triggers derlin-1 
mRNA overexpression; although the role of derlin-1 in the 
protection of thymocytes from apoptosis is still unknown, 
knock-down of derlin-1 by abrogating p62 degradation, 
results in blockage of autophagy flux [38].
In CPS-treated thymocytes, reduction of BiP, 
Grp94 UPR protein levels, as results of UPR inhibition, 
was completely reverted by pretreatment with 4-PBA 
or CQ treatment, ER stress and autophagy inhibitors, 
respectively, strongly suggesting that CPS-induced 
autophagy is a TRPV1-dependent ER-stress-stimulated 
process. 
The contribution of TRPV1 in the autophagy and 
proteasome cross-talk was also evaluated in thymocytes 
from TRPV1 KO mice. Genetic deletion of TRPV1 
results in increased basal levels of p62 and in a defective 
autophagic response to the mTOR inhibitor and autophagy 
inducer rapamycin. The p62/SQSTM1 is a multifunctional 
protein selectively degraded by autophagy but not by UPS 
[20, 38] that accumulates when autophagy function is 
inhibited [39, 40]. The p62 accumulation during autophagy 
inhibition appears to be responsible for the defective UPS 
function, as p62 silencing attenuates the accumulation of 
proteasome substrates caused by autophagy inhibition, 
and the pharmacological inhibition of the proteasome 
increases p62 expression [41, 42]. In this view, impaired 
autophagy due to TRPV1 genetic deletion by inducing 
p62 accumulation reduces proteasome functions. The 
decreased proteasome activity observed in TRPV1 KO 
thymocytes was associated with loss of AMPK activity 
and a decreased p27 expression compared with WT 
thymocytes [15]. Inhibition of AMPK by compound C or 
by shRNA-mediated depletion of LKB reduces activation 
of autophagy by rapamycin, and shRNA-mediated 
depletion of p27 inhibits rapamycin-induced autophagy 
[43]. Thus, the AMPK/p27 pathway deregulation observed 
in TRPV1 KO thymocytes, exacerbates the severity of 
the autophagy/proteasome defects, further promoting the 
Table 1: CPS induces UPS gene expression changes.
Ref Seq Symbol Description
Fold change
CPS-treated vs 
untreated 
NM_007527 Bax Bcl2-associated X protein -2.04±0.03*
NM_013760 Dnajb9 Dnaj (Hsp40) homolog, subfamily B, member 9 -2.09±0.08*
NM_022310 Hspa5 Heat shock protein 5 -2.79±0.02*
NM_153526 Insig1 Insulin induced gene 1 -3.31±0.02*
NM_172307 Mbtps2 Membrane-bound transcription factor peptidase, site 2 -2.10±0.02*
NM_133933 Rpn1 Ribophorin 1 -2.40±0.04*
NM_013842 Xbp1 X-box binding protein 1 -2.67±0.05*
NM_013558 Hspa1l Heat shock protein 1-like -2.27±0.43*
NM_024207 Derl1 Der1-like domain family, member 1 +2.65±0.03*
NM_033562 Derl2 Der1-like domain family, member 2 +2.09±0.02*
NM_026184 Ero1lb ERO1-like beta (S.Cerevisiae) +2.10±0.04*
RT-PCR array in mRNA samples from thymocytes untreated and treated with CPS for 60 min. The expression levels were 
normalized using the housekeeping gene GAPDH and calculated by the ∆∆Ct method. Data, shown as fold change, represent 
the mean ± SD of three experiments. Untreated thymocyte mRNA was used as calibrator. *p < 0.01 vs untreated cells. 
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reduction of DP thymocyte number. 
Our results in TRPV1 KO thymocytes, also provide 
evidence of a reduction of BiP and Grp94 UPR proteins 
and increase of ERp57 levels. Knock-down or inhibition 
of ERp57 resulted in decreased death-inducing signaling 
complex and caspase activity [44]. On the contrary, 
autophagy failure, induced by compromised UPR, has 
been found to increase the ERp57 expression in beta cell 
islets from Atg7-deficient mice [45]. Thus, the reduction of 
ERp57 in CPS-treated WT thymocytes may be the result 
of enhanced autophagic survival, as well as the increase 
of ERp57 level in TRPV1 KO thymocytes could promote 
apoptotic death caused by autophagic failure. 
In the same view, Atf4 induction by prolonged 
stress exposure triggers apoptosis in cancer cells [46]; so, 
the enhancement of Atf4 protein expression evidenced 
in TRPV1 KO thymocytes, may lead to increased 
susceptibility of thymocytes to apoptotic stimuli.
In addition, as result of double defects in autophagic 
and proteasome degradation systems, increased levels of 
apoptotic thymocytes associated with a reduction of total 
and DP thymocyte number was found in TRPV1 KO mice. 
Accordingly, the proteasome inhibitor Bortezomib, results 
in a dramatic decrease of thymocytes by inducing ER 
stress-apoptosis [47]. 
Proteasome inhibition has been also found to 
interfere with thymic selection, and thereby to influence 
the survival of DP and SP thymocytes [48, 49]. 
Differentiation of immature DP thymocytes into mature 
SP CD4+ and CD8+ T cells is referred as positive selection 
[26, 50], and requires physical contact with thymic cortical 
epithelium. Indeed, TCRβ and CD2 co-engagement by 
increasing survival signals [27] promotes a differentiation 
pathway resulting in generation of SP CD4+ T cells from 
DP thymocytes [26]. This pathway requires two distinct 
steps in which expression of both co-receptors CD4 
and CD8 is reduced (CD4lowCD8low, DPdull), followed 
by selective re-expression of CD4 with the CD4low cells 
representing the immediate precursor of mature CD4+ 
cells. In this regard, our findings add new straightforward 
data on the role of TRPV1 in thymocyte maturation. In 
fact, its absence is responsible for the increased percentage 
of apoptotic cells after TCR engagement, likely due to the 
loss of the survival signals that normally characterize the 
positive selection. The positive selection stimulates the 
maturation of DP thymocytes in SP CD4+ cells both in 
TRPV1 KO and WT cells; whereas, the impaired TRPV1 
signaling in TCRβ/CD2-stimulated thymocytes markedly 
reduced the percentage of mature SP CD4+ thymocytes 
and increased that of immature DP CD4lowCD8+ and SP 
CD4low cells, compared to WT thymocytes. Therefore, 
the absence of TRPV1 impairs positive selection by 
reducing/delaying CD4+ thymocyte maturation. Moreover, 
a reduced percentage of mature CD8+ and CD4+ T cells 
was observed in PBMC and spleen from TRPV1 deficient 
mice. These findings are in agreement with previous 
reports demonstrating that an impaired thymic autophagy 
affects the distribution of mature SP CD4 and CD8 T cells 
in the periphery [51]. 
TRPV1, constitutively expressed in mouse and 
human CD4+ T cells, is a component of the TCR signaling 
complex. It is rapidly recruited to TCR clusters upon TCR 
stimulation in a Src-dependent manner, and contributes to 
CD4+ T cell activation. In response to TCR stimulation 
TRPV1 is rapidly tyrosine phosphorylated by the Lck 
kinase that regulates TRPV1 activity in CD4+ T cells [14]. 
Analysis of TCR signaling evidenced a diminished p38 
and Jnk activation and NF-kB and NFAT-1 translocation 
to the nucleus in TRPV1 KO CD4+ T respect to WT cells 
[14]. Thus, the loss of TRPV1 resulted in a reduction of 
SP CD4 thymocytes, further supporting the recent findings 
on the intrinsic role of TRPV1 in the activation of and 
acquisition of pro-inflammatory properties by CD4+ T 
cells [14]. Thus, in WT thymocytes, TRPV1 activation, 
by inducing ER stress and proteasome dysfunction, 
triggers a compensatory autophagy that inhibits the UPR 
response and rescues DPdull thymocytes from apoptosis. 
On the contrary, in TRPV1 KO thymocytes, characterized 
by defects in autophagy and proteasome system, the 
impaired TRPV1 signalling, stimulates the apoptosis of 
DP thymocytes and impairs thymocyte maturation induced 
by TCRβ/CD2 stimulation, leading to a decrease in the 
percentage of mature SP CD4+. 
Thus, pharmacological modulation of TRPV1 
expression and functions could represent a new 
therapeutic strategy for restraining or stimulating different 
inflammatory T cell responses.
MATERIALS AND METHODS
Animals
C57BL/6 (WT) and B6.129X1-Trpv1tm1Jul/J 
(TRPV1 KO) male mice were purchased from Harlan 
(Udine, Italy) and Jackson Laboratory (Bar Harbor, ME, 
USA), respectively, and housed as described previously 
[12]. Five TRPV1 KO and five WT animals (6-10 week-
old) were sacrificed for each experiment in accordance 
with the U.S. National Institutes of Health’s “Guidelines 
for the Care and Use of Laboratory Animals”. Before and 
after sacrifice respectively, mice were weighted and thymi 
were measured by caliper without significant differences 
between WT and TRPV1 deficient mice. 
Cell preparation and culture conditions
Thymi were teased, and cellular debris were 
removed by washing. Thymocytes were isolated by 
centrifugation on a Lympholyte-M (Cederlane, Burlington, 
Canada) gradient and washed in RPMI 1640 medium 
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supplemented with 5x 10-5 M β-mercaptoethanol, 2 mM 
glutamin, 100 U/ml penicillin, 100 µg/ml streptomycin, 
and 10% fetal calf serum (FCS). Cell purity (99%) was 
assessed by FACS analysis using anti-CD3 monoclonal 
antibody (mAb) (clone KT3) (10 μg/mL, Novus 
Biologicals, Littleton, CO, USA). Briefly, double 
positive (DP) CD4/CD8 cells were purified from 1x108/
ml total thymocytes by using the EasySep CD4 and CD8 
purification kits (Stem Cell Technologies, Vancouver, 
Canada) according to the manufacturer’s instructions. The 
resultant cell population was enriched for CD4+CD8+ DP 
cells (approximately 97% of purified thymocytes). 
To mimic positive selection, thymocytes were 
stimulated by anti-TCRβ mAb (clone: H57-597) plus anti-
CD2 mAb (clone: 12-15) (10 μg/mL, Novus Biologicals) 
cross-linking. Briefly, thymocytes were cultured in vitro 
for 18 h in mAb-coated (stimulated thymocytes) or 
uncoated (non-stimulated thymocytes) Petri dishes (day 
1) and then incubated for additional 12 h (day 2) in the 
absence of mAbs. 
Compounds
Rapamycin (an autophagy inducer inhibiting the 
mammalian target of rapamycin mTOR, 10 ng/ml), 
chloroquine (CQ, an autophagy inhibitor preventing the 
fusion between the autophagosome and lysosomes, 100 
μM), capsaicin (CPS, TRPV1 agonist, 10 μM), capsazepine 
(CPZ, a synthetic, competitive and selective antagonist of 
TRPV1, 1 μM), 4-phenylbutyric acid (4-PBA, ER stress 
inhibitor, 5 mM), Ethylenediaminutesetetraacetic acid 
(EDTA), a calcium chelating agent, 5 mM), N-acetyl-L-
cysteine (NAC, a free radical scavenger, 10 mM), trypan 
blue, dimethyl sulfoxide (DMSO) as well as the substrates 
for assaying the chymotrypsin-like (ChT-L), trypsin-like 
(T-L), peptidylglutamyl-peptide hydrolyzing (PGPH) 
and proteasome inhibitors, Z-Gly-Pro-Phe-Leu-CHO 
and lactacystin, were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). 
Measurement of proteasome activity in cell lysates 
Cells were washed in PBS and centrifuged at 1,600 
g for 5 minutes. The pellet was resuspended in lysis buffer 
(20 mM Tris, pH 7.4, 250 mM sucrose, 1 mM EDTA and 
5 mM β-mercaptoethanol) and passed through a 29-gauge 
needle at least ten times. Lysates were centrifuged at 
12,000 x g for 15 minutes and the supernatants were stored 
at -80°C. Protein concentration was determined by the 
method of Bradford using bovine serum albumin (BSA) 
as standard. 
Proteasome peptidase activity in cell lysates was 
determined with fluorogenic peptides: Suc-Leu-Leu-Val-
Tyr-AMC was used for the chymotrypsin-like (ChT-L) 
activity, Z-Leu-Ser-Thr-Arg-AMC for the trypsin-
like (T-L) activity and Z-Leu-Leu-Glu-AMC for the 
peptidylglutamyl-peptide hydrolyzing (PGPH) activity. 
The incubation mixture contained 1 μg of cell lysate, the 
appropriate substrate and 50 mM Tris-HCl pH 8.0, up to 
a final volume of 100 μL. Incubation was performed at 37 
°C and after 60 minutes the fluorescence of the hydrolysed 
7-amino-4-methyl-coumarin (AMC) was detected on a 
SpectraMax Gemini XPS microplate reader (λexc = 365 
nm, λem = 449 nm). The 26S proteasome ChT-L activity 
was tested using Suc-Leu-Leu-Val-Tyr-AMC as substrate 
and a 50 mM Tris-HCl pH 8.0 buffer containing 10 mM 
MgCl2, 1 mM dithiothreitol, and 2 mM ATP. The effective 
20S proteasome contribution to short peptide cleavage 
was evaluated performing control experiments using the 
specific proteasome inhibitors Z-Gly-Pro-Phe-Leu-CHO 
and lactacystin (5 μM in the reaction mixture) and then 
subtracting the obtained fluorescence values from the 
values obtained in cell lysates. 
Immunofluorescence and flow cytometry
Thymocytes from WT or TRPV1 KO mice 
were stained with anti-CD4-PE (clone: RM4-5) and/
or anti-CD8-Cy5 (clone 53-6.7) mAb (1μl/1x106 
cells; BD Biosciences, Milan, Italy) and analyzed by 
a FACScan cytofluorimeter (BD Biosciences) using 
the CellQuest software. In some experiments, double 
immunofluorescence for CD4 and CD8 was performed on 
thymocyte from WT mice pre-treated for 1h with 4-PBA 
(5 mM), CQ (100 μM) or NAC (10 mM) and then treated 
with CPS (10 μM) for 2h. Moreover, the percentage of 
CD4 and CD8 positive cells was evaluated on thymocytes 
from WT or KO mice, un-stimulated or stimulated to 
mimic thymic positive selection. To investigate the role 
of TRPV1 in the activation of thymocytes, cells from 
WT mice were treated or not with CPS for 2 h, and then 
stained with anti-CD25-FITC (clone PC61) (1μl/1x106 
cells, Biolegend, San Diego, USA) or anti CD69-PE 
(clone H1.2F3) mAb (1μl/1x106 cells, Biolegend).
Western blot
Thymocytes from WT and KO mice were lysed 
as described previously [12]. Samples were separated 
on SDS-PAGE and transferred onto Hybond-C extra 
membranes (GE Healthcare, Milan, Italy). Membranes 
were incubated in 5% low-fat dry milk for 1 h and then 
overnight at 4°C in the primary antibodies solution: 
rabbit anti-p27 Kip1, anti-p62, anti-Grp94/gp96, anti-
BiP/Grp78, anti-ERp57/Grp58, anti-Atf-4, anti-AMPK 
and anti-pAMPK (1:1000; Cell Signaling Technology, 
Danvers, MA, USA); rabbit anti-LC3 (2 μg/mL; Novus 
Biologicals); mouse anti-GAPDH (1:5000; Sigma-
Aldrich). Thereafter, membranes were blotted with the 
respective horseradish peroxidase-conjugated anti-rabbit 
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(1:2000; Cell Signaling Technology), anti-mouse (1:2000; 
Cell Signaling Technology) for 1 h. The detection was 
performed using the LiteAblot Plus or the LiteAblot 
Turbo (EuroClone, Milano, Italy) kits and densitometric 
analysis was carried out by evaluating three independent 
experiments by a ChemiDoc using Quantity One 
software (Bio-Rad, Hercules, CA, USA). Each sample 
was compared with its loading control (GAPDH) for 
quantification. In some experiments, thymocytes from 
WT mice were treated or not with CPS for different times. 
Moreover, thymocytes were pre-treated for 1 h with NAC, 
EDTA, CPZ, 4-PBA or CQ, before the addition of CPS for 
2 h. In addition, TRPV1 KO thymocytes were treated for 
different times with Rapamycin.
Annexin V and PI staining
Cell death was evaluated using Annexin 
V-fluorescein isothiocyanate (Annexin-FITC, BD 
Biosciences) and propidium iodide (PI, 2 μg/ ml, Sigma-
Aldrich) followed by biparametric FACS analysis. Cells 
were stained with 5 μl of Annexin V-FITC and/or PI 
for 10 minutes at room temperature and washed once 
with binding buffer (10mM Hepes/NaOH pH 7.4, 140 
mM NaCl, 2.5 mM CaCl2). The percentage of positive 
cells determined over 10,000 events was analyzed by a 
FACScan cytofluorimeter using the CellQuest software. 
RNA isolation, reverse transcription, and RT-PCR 
profiler array
Total RNA was extracted from thymocytes with 
the RNeasy mini kit (Qiagen, Valencia, CA, USA). Total 
RNA (1 μg) was subjected to reverse transcription using 
the ReactionReady first-strand cDNA kit (SuperArray 
Bioscience, Frederick, MD, USA). qRT-PCR was 
performed using the iQ5 Multicolor RT-PCR detection 
system (Bio-Rad), the RT2 real-time SYBR Green 
PCR mix, and the mouse Unfolded Protein Response 
PCR Array (SuperArray Bioscience), according to the 
manufacturer’s instructions. 
Statistical analysis
The statistical significance was determined by 
Student’s t test and by ANOVA with Bonferroni post-test. 
No statistically significant difference was found between 
untreated and vehicle (DMSO)-treated thymocytes (data 
not shown).
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